A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetesROSENSTOCK, J; DAVIES, M; HOME, P. D et al.Diabetologia (Berlin). 2008, Vol 51, Num 3, pp 408-416, issn 0012-186X, 9 p.Article

An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetesSCHIAFFINI, Riccardo; CIAMPALINI, Paolo; SPERA, Sabrina et al.Diabetes/metabolism research and reviews (Print). 2005, Vol 21, Num 4, pp 347-352, issn 1520-7552, 6 p.Article